Investors may wish to attend a web conference where the EIGA PHARMA RESEARCH TEAM will be giving a live presentation every Friday at 11am GMT for Europe and 3pm for USA GMT and will be able to answer questions after the conference.
courtesy of Kidica
EIGA PHARMA SWITZERLAND AG 30% of the equity £5.5m
EIGA PHARMA OPERATIING COMPANY PLC 50% of equity £50m
Disclaimer
The information contained on this web site is not an invitation or solicitation to invest in the shares of the company. It is produced for the purpose of description of the activities of the company, the research, the products and treatments. Any use of this information for the purpose of a financial transaction should be conducted through an independent financial advisor or professional consultant.
